Publication search

Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic ch...

Published in Journal of Neurology

Background and purposeFocal epilepsy of unknown cause (FEUC) is an under-investigated topic despite its remarkable frequency. We aimed to report the long-term follow-up findings along with the drug-response, 5 year remission rates and diagnostic changes to give an insight about the heterogeneous characteristics of FEUC.MethodsDemographic, clinical,...

Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron dis...

Published in Journal of Neurology

IntroductionThe importance of elucidating the relationships between pain, mood and quality of life (QoL) amongst people with amyotrophic lateral sclerosis/motor neuron disease is evident to clinicians, yet the literature is limited and inconsistent. We explored the relationships between pain, depression, anxiety and QoL to reconcile the previous co...

Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease

Published in Journal of Neurology

BackgroundClinical phenotypic heterogeneity represents a major barrier to trials in motor neuron disease (MND) and objective surrogate outcome measures are required, especially for slowly progressive patients. We assessed responsiveness of clinical, electrophysiological and radiological muscle-based assessments to detect MND-related progression.Mat...

Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorp...

Published in Journal of Neurology

The Joint Editors-in-Chief have retracted this article [1] at the request of the University of Bergen and the Norwegian Board of Health Supervision.

Correction to: A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging feat...

Published in Journal of Neurology

The author would like to correct the errors in the publication of the original article. The corrected details are given below for your reading.

Acute posterior multifocal placoid pigment epitheliopathy after alemtuzumab treatment for relapsing–remitting multiple s...

Published in Journal of Neurology

Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis

Published in Journal of Neurology

BackgroundNo postmarketing randomised clinical trials are available about alemtuzumab, and real-world data are limited. We aimed to analyse the efficacy and safety of alemtuzumab in a single-centre cohort of patients with relapsing–remitting MS.MethodsPatients who took alemtuzumab were enrolled. We collected the following data: age, sex, MS history...

Non-motor symptoms in Huntington’s disease: a comparative study with Parkinson’s disease

Published in Journal of Neurology

Background/aimsThe presence of non-motor symptoms in Huntington’s disease (HD) has not been systematically assessed so far. Our objective was to know their prevalence and to compare it with a cohort of patients with Parkinson’s disease (PD).Materials and methodsParticipants were consecutively recruited from our outpatient clinic. They were assessed...

Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel varia...

Published in Journal of Neurology

Glucose transporter type 1 deficiency syndrome (Glut1 DS) is a rare neurological disorder caused by impaired glucose delivery to the brain. The clinical spectrum of Glut1 DS mainly includes epilepsy, paroxysmal dyskinesia (PD), developmental delay and microcephaly. Glut1 DS diagnosis is based on the identification of hypoglycorrhachia and pathogeni...

Increased risk for subarachnoid hemorrhage in patients with sleep apnea

Published in Journal of Neurology

ObjectivesRecent retrospective studies found sleep disorders, including obstructive sleep apnea and its symptoms to occur more often in patients following aneurysmal subarachnoid hemorrhage, but studies investigating the incidence of subarachnoid hemorrhage in patients with diagnosed obstructive sleep apnea [OSA] compared to other sleep disorders a...